Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly

Current Pharmaceutical Design - United Arab Emirates
doi 10.2174/138161210793176446
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Long-Term Health Related Quality of Life Following Intensive Care During Treatment for Haematological Malignancies

PLoS ONE
Multidisciplinary
2014English

Aggressive Haematological Malignancies

Virchows Archiv
MedicineForensic MedicinePathologyCell BiologyMolecular Biology
2017English

Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies

PLoS ONE
Multidisciplinary
2011English

Chemical Modification of Melphalan as a Key to Improving Treatment of Haematological Malignancies

Scientific Reports
Multidisciplinary
2020English

Epigenetic Inactivation of the Hsa-miR-203 in Haematological Malignancies

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2011English

Evaluation of the Cost-Effectiveness of Dexrazoxane for the Prevention of Anthracycline-Related Cardiotoxicity in Children With Sarcoma and Haematologic Malignancies: A European Perspective

Cost Effectiveness and Resource Allocation
Health Policy
2020English

Effect of Serum Vitamin D Deficiency in the Prevalence of Haematological Malignancies

International Journal of Clinical Biochemistry and Research
2018English

Whole Body MRI and PET/CT in Haematological Malignancies

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2007English

Antibody-Drug Conjugates for the Therapy of Thoracic Malignancies

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy